MDWD MediWound Ltd.
$13.11▼ -4.38%
Healthcare
Other
After hours
$13.11▲ +0.00%
Sep 11, 7:30 PM ET
Volume 78.3K
Avg Volume (10D) 148.0K
Key Metrics & Fundamentals
Market Cap
$169.25M
P/E Ratio
–
Div Yield
–%
52W Range
12.52 - 20.03
% vs 50 MA
-1.51%
% vs 200 MA
-15.31%
RSI-14
54.2
MACD Histogram
+0.1400
Beta (1Y vs SPY)
0.68
Free Cash Flow
-$10.20M
Gross Rev
$3.09M
Gross Profit
$337,000
EBITDA
-$9.06M
COGS
$2.76M
Operating Exp
$9.80M
Operating Income
-$9.46M
EBIT
-$9.46M
Pretax Income
-$7.36M
Net Income
-$7.39M
EPS (Diluted)
-0.77
Price & Volume History
Loading chart…
Recent News

MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 2, 2026 11:00 AM

MediWound (MDWD) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 12:42 PM
Oppenheimer Adjusts Price Target on MediWound to $30 From $32, Keeps Outperform Rating
MT Newswires · Aug 14, 2026 12:45 PM

MediWound Ltd. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 12:30 PM
MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record NexoBrid Sales and EscharEx ...
GuruFocus.com · Aug 13, 2026 11:07 PM

MediWound Q2 Earnings Call Highlights
MarketBeat · Aug 13, 2026 6:04 PM

MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 13, 2026 12:15 PM
MediWound: Q2 Earnings Snapshot
Associated Press · Aug 13, 2026 11:11 AM

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 13, 2026 11:00 AM
ProKidney Corp. (PROK) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 10, 2026 9:55 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See MDWD's money flow as a full page
Social Sentiment
Avg +0.30 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.